Pig kidney transplant sets record at 271 days before failing; patient receives human kidney

Tim Andrews, the recipient of the landmark xenotransplant, said the pig kidney gave him "hope" and spared him months of gruelling dialysis sessions. He described the idea of a pig organ as a "light at the end of the tunnel" when faced with a seven-year wait for a human kidney—far longer than the average five-year survival on dialysis.

The breakthrough, reported by the team at Mass General Brigham, demonstrates that genetically modified pig organs can serve as a viable "bridge" while patients wait for human donors. In the US, around 100,000 people are on the kidney transplant waiting list, but only about 25,000 transplants are performed each year. More than 7,000 people in the UK are also awaiting a kidney.

"I had a little bit of a shortage of time… it becomes very depressing," Andrews said. "Hope is the biggest thing, the chance to be free from the [dialysis] machine and live your life."

The pig kidney eventually failed and was removed, prompting a short bout of dialysis before a human donor was found. The case marks the longest recorded survival of a pig organ in a human patient, building on previous xenotransplantation attempts that lasted weeks or months.

Why This Matters

Demonstrates that pig kidneys can sustain a human patient for over nine months, offering a potential lifeline for the 100,000+ Americans waiting for a kidney.
Reduces reliance on dialysis, which drastically limits quality of life and survival—patients on dialysis live about five years on average.
Validates the concept of using animal organs as a "bridge" to human transplantation, potentially easing the chronic organ shortage until alternatives mature.

Background

Xenotransplantation—using organs from other species—has been pursued for decades due to the severe shortage of human donor organs. Genetically modified pigs, whose organs are less likely to be rejected, have emerged as the leading candidate. Prior attempts in living patients had lasted only a few months; the 271-day record represents a significant milestone. However, immune rejection and organ failure remain major hurdles. The field has advanced since the first experimental pig kidney transplants in brain-dead patients and early living-patient cases.

Key Perspectives

Patient Tim Andrews: Received a chance at life without years of dialysis. He expressed gratitude for the "hope" the pig kidney gave him and a willingness to participate in experimental treatment when time was running out. Mass General Brigham team (Dr. Tatsuo Kawai, Dr. Leonardo Riella): View the case as proof that pig organs can function long enough to serve as a bridge therapy. The 271-day mark exceeds all previous records in living patients. Critics/Skeptics: Caution that one successful case does not guarantee broad applicability. Long-term immune suppression, unknown risks of porcine viruses, and the eventual failure of the organ underscore the need for larger, controlled trials before xenotransplantation becomes routine.

What to Watch

Regulatory decisions from the FDA on expanded clinical trials for pig kidney transplants.
Follow-up data on whether the human kidney recipient experiences any complications linked to the prior xenotransplant.
Advances in genetic engineering of donor pigs to further reduce rejection and extend organ survival.

ZOTPAPER